المؤلفون: Kerner H; Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel.; Family Medicine Department, Technion-Israel Institute of Technology, Haifa, Israel., Samuels N; Tal Center for Integrative Oncology, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel., Ben Moshe S; Sleep Laboratory and Clinics, Clalit Health Services, Haifa and Western Galilee and Carmel Medical Center, Kiryat Bialik, Israel., Sharabi IS; Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel.; Graduate Studies Authority, Haifa University, Haifa, Israel., Ben-Arye E; Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel.; Family Medicine Department, Technion-Israel Institute of Technology, Haifa, Israel.

المصدر: BMJ supportive & palliative care [BMJ Support Palliat Care] 2020 Sep; Vol. 10 (3), pp. e21. Date of Electronic Publication: 2017 Jul 14.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101565123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-4368 (Electronic) Linking ISSN: 2045435X NLM ISO Abbreviation: BMJ Support Palliat Care Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Complementary Therapies/*methods , Integrative Medicine/*methods , Precision Medicine/*methods , Sleep Wake Disorders/*therapy, Adult ; Breast Neoplasms/drug therapy ; Breast Neoplasms/physiopathology ; Female ; Genital Neoplasms, Female/drug therapy ; Genital Neoplasms, Female/physiopathology ; Humans ; Israel ; Middle Aged ; Program Evaluation ; Prospective Studies ; Quality of Life ; Sleep ; Sleep Wake Disorders/chemically induced ; Surveys and Questionnaires

المؤلفون: Rossi E; 1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy ., Noberasco C; 1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy ., Picchi M; 1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy ., Stefano MD; 1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy ., Rossi A; 1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy ., Nurra L; 1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy ., Ventura L; 2 ISPRO, Oncological Network, Prevention and Research Institute , Firenze, Italy .

المصدر: Journal of alternative and complementary medicine (New York, N.Y.) [J Altern Complement Med] 2018 Sep/Oct; Vol. 24 (9-10), pp. 933-941.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9508124 Publication Model: Print Cited Medium: Internet ISSN: 1557-7708 (Electronic) Linking ISSN: 10755535 NLM ISO Abbreviation: J Altern Complement Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/therapeutic use , Integrative Medicine* , Integrative Oncology*, Drug-Related Side Effects and Adverse Reactions/*therapy , Neoplasms/*therapy, Adult ; Aged ; Complementary Therapies ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies

المؤلفون: Tsai CH; Graduate Institute of Integrated Medicine, China Medical University, Taichung 40402, Taiwan.; Department of Neurology, National Taiwan University Hospital Yunlin Branch, Yunlin 64041, Taiwan., Lin YH; Graduate Institute of Integrated Medicine, China Medical University, Taichung 40402, Taiwan.; Department of Chinese Medicine of E-Da Cancer Hospital, Kaohsiung 82445, Taiwan., Li YS; Graduate Institute of Integrated Medicine, China Medical University, Taichung 40402, Taiwan.; Department of Chinese Medicine of Jiannren Hospital, Kaohsiung 811504, Taiwan., Ho TL; International Master's Program of Biomedical Sciences, China Medical University, Taichun 40402, Taiwan., Hoai Thuong LH; International Master's Program of Biomedical Sciences, China Medical University, Taichun 40402, Taiwan., Liu YH; Graduate Institute of Integrated Medicine, China Medical University, Taichung 40402, Taiwan.; Department of Medical Genetics and Medical Research, China Medical University Hospital, Taichung 40402, Taiwan.; Drug Development Center, China Medical University, Taichung 40402, Taiwan.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2021 Aug 26; Vol. 22 (17). Date of Electronic Publication: 2021 Aug 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Disease Susceptibility* , Integrative Medicine*/methods , Integrative Medicine*/trends, Antineoplastic Agents/*adverse effects , Drug-Related Side Effects and Adverse Reactions/*etiology , Peripheral Nervous System Diseases/*etiology, Antineoplastic Agents/therapeutic use ; Clinical Trials as Topic ; Combined Modality Therapy ; Disease Management ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Drug-Related Side Effects and Adverse Reactions/therapy ; Humans ; Peripheral Nervous System Diseases/diagnosis ; Peripheral Nervous System Diseases/therapy ; Treatment Outcome

المؤلفون: Lee YC; Department of Chinese Medicine, MacKay Memorial Hospital, Taipei, Taiwan., Chen YH; Division of Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan., Huang YC; Department of Medical Research, China Medical University Hospital, School of Chinese Medicine, China Medical University, Taichung, Taiwan., Lee YF; Department of Nursing, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan., Tsai MY; Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

المصدر: Journal of alternative and complementary medicine (New York, N.Y.) [J Altern Complement Med] 2020 Sep; Vol. 26 (9), pp. 833-840.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9508124 Publication Model: Print Cited Medium: Internet ISSN: 1557-7708 (Electronic) Linking ISSN: 10755535 NLM ISO Abbreviation: J Altern Complement Med Subsets: MEDLINE

مواضيع طبية MeSH: Integrative Medicine* , Medicine, Chinese Traditional* , Phytotherapy*, Antineoplastic Agents/*therapeutic use , Breast Neoplasms/*drug therapy , Drugs, Chinese Herbal/*therapeutic use, Activities of Daily Living ; Adult ; Combined Modality Therapy ; Female ; Humans ; Integrative Oncology ; Middle Aged ; Prognosis ; Prospective Studies ; Quality of Life ; Survival Analysis ; Taiwan ; Treatment Outcome

المؤلفون: Ben-Arye E, River Y, Keshet Y; Department of Sociology and Anthropology, Western Galilee Academic College, Galilee., Lavie O; Department of Obstetrics and Gynecology, Gynecologic Oncology Service, Carmel Medical Center, Haifa., Israeli P, Samuels N

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2018 Jun; Vol. 28 (5), pp. 1045-1049.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Complementary Therapies* , Precision Medicine*, Antineoplastic Agents/*adverse effects , Bridged-Ring Compounds/*adverse effects , Peripheral Nervous System Diseases/*therapy , Taxoids/*adverse effects, Aged ; Breast Neoplasms/drug therapy ; Female ; Genital Neoplasms, Female/drug therapy ; Humans ; Integrative Medicine ; Middle Aged ; Peripheral Nervous System Diseases/chemically induced

المؤلفون: Zhang D, Yang YF

المصدر: Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine [Zhongguo Zhong Xi Yi Jie He Za Zhi] 2015 Aug; Vol. 35 (8), pp. 1022-4.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Gai yan jiu yuan Country of Publication: China NLM ID: 9211576 Publication Model: Print Cited Medium: Print ISSN: 1003-5370 (Print) Linking ISSN: 10035370 NLM ISO Abbreviation: Zhongguo Zhong Xi Yi Jie He Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Integrative Medicine*, Antineoplastic Agents/*adverse effects , Organoplatinum Compounds/*adverse effects , Peripheral Nervous System Diseases/*chemically induced, Humans ; Oxaliplatin

المؤلفون: Shalom-Sharabi I; Integrative Oncology Program, The Oncology Service and Lin Medical center, Clalit Health Services, Haifa and Western Galilee District, 35 Rothschild St., Haifa, Israel., Samuels N; Integrative Oncology Program, The Oncology Service and Lin Medical center, Clalit Health Services, Haifa and Western Galilee District, 35 Rothschild St., Haifa, Israel.; Tal Center for Integrative Oncology, Sheba Medical Center, Institute of Oncology, Tel Hashomer, Israel., Lavie O; Department of Obstetrics and Gynecology, Gynecologic Oncology Service, Carmel Medical Center, Haifa, Israel., Lev E; Department of Eretz Israel Studies, University of Haifa, Haifa, Israel., Keinan-Boker L; Faculty of Social Welfare and Health Sciences, School of Public Health, University of Haifa, Haifa, Israel.; Israel Center for Disease Control, Israel Ministry of Health, Haifa, Israel., Schiff E; Department of Internal Medicine, and the Integrative Medicine Service, Bnai-Zion Hospital, Haifa, Israel., Ben-Arye E; Integrative Oncology Program, The Oncology Service and Lin Medical center, Clalit Health Services, Haifa and Western Galilee District, 35 Rothschild St., Haifa, Israel. eranben@netvision.net.il.; Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. eranben@netvision.net.il.; Clalit Health Services, Haifa and Western Galilee District, Haifa, Israel. eranben@netvision.net.il.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2017 Jul; Vol. 143 (7), pp. 1243-1254. Date of Electronic Publication: 2017 Feb 28.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Antineoplastic Agents/*adverse effects , Gastrointestinal Diseases/*chemically induced , Gastrointestinal Diseases/*therapy , Integrative Medicine/*methods, Adult ; Aged ; Breast Neoplasms/drug therapy ; Complementary Therapies/methods ; Female ; Genital Neoplasms, Female/drug therapy ; Humans ; Middle Aged ; Patient Compliance

المؤلفون: Hack CC; 1 Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-European Metropolitan area Nuremberg (CCC ER-EMN), Germany., Fasching PA; 1 Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-European Metropolitan area Nuremberg (CCC ER-EMN), Germany., Fehm T; 2 Universitäts-Frauenklinik Düsseldorf, Düsseldorf, Germany.; 3 Department für Frauengesundheit, Universitätsklinikum Tübingen, Eberhard-Karls-Universität, Tübingen, Germany., de Waal J; 4 Frauenklinik im Klinikum Dachau, Dachau, Germany., Rezai M; 5 Luisenkrankenhaus Düsseldorf, Düsseldorf, Germany., Baier B; 4 Frauenklinik im Klinikum Dachau, Dachau, Germany., Baake G; 6 Onkologische Praxis Pinneberg, Pinneberg, Germany., Kolberg HC; 7 Marienhospital Bottrop, Bottrop, Germany., Guggenberger M; 8 Klinikum Tuttlingen, Germany., Warm M; 9 Brustzentrum, Universitäts-Frauenklinik, Cologne, Germany.; 10 Brustzentrum, Klinken der Stadt Cologne gGmbH, Holweide, Germany., Harbeck N; 3 Department für Frauengesundheit, Universitätsklinikum Tübingen, Eberhard-Karls-Universität, Tübingen, Germany.; 11 Brustzentrum der Universität München, Frauenkliniken Grosshadern und Maistrasse, Munich, Germany., Wuerstlein R; 3 Department für Frauengesundheit, Universitätsklinikum Tübingen, Eberhard-Karls-Universität, Tübingen, Germany.; 11 Brustzentrum der Universität München, Frauenkliniken Grosshadern und Maistrasse, Munich, Germany., Deuker JU; 12 Vinzenzkrankenhaus Hanover gGmbH, Hanover, Germany., Dall P; 13 Frauenklinik, Städtisches Klinikum Lüneburg, Lüneburg, Germany., Richter B; 14 Elblandkliniken Meissen-Radebeul, Radebeul, Germany., Wachsmann G; 15 Kreiskrankenhaus Böblingen, Böblingen, Germany., Brucker C; 16 Universitätsklinik für Frauenheilkunde, Paracelsus Medizinische Privatuniversität, Nuremberg, Germany., Siebers JW; 17 Frauenklinik der St. Josefsklinik, Offenburg, Germany., Fersis N; 18 Frauenklinik, Klinikum Bayreuth GmbH, CCC ER-EMN, Bayreuth, Germany., Kuhn T; 19 Karl-Olga-Krankenhaus, Stuttgart, Germany., Wolf C; 20 Medizinisches Zentrum Ulm, Ulm, Germany., Vollert HW; 21 Klinikum Friedrichshafen, Friedrichshafen, Germany., Breitbach GP; 22 Städtisches Klinikum Neunkirchen Gynäkologie und Geburtshilfe, Neunkirchen, Germany., Janni W; 23 Frauenklinik des Universitätsklinikums Ulm, Ulm, Germany., Landthaler R; 24 Gynäkologische Praxis in der Kreisklinik Krumbach, Krumbach, Germany., Kohls A; 25 Evangelisches Krankenhaus Ludwigsfelde-Teltow, Ludwigsfelde, Germany., Rezek D; 26 Marien-Hospital Wesel, Wesel, Germany., Noesslet T; 27 Frauenklinik am Kreiskrankenhaus Hameln, Hameln, Germany., Fischer G; 28 Landkreis Mittweida Krankenhaus gGmbH, Mittweida, Germany., Henschen S; 29 Johanniter Krankenhaus Genthin Stendal gGmbH, Stendal, Germany., Praetz T; 30 Caritas-Krankenhaus, Bad Mergentheim, Germany., Heyl V; 31 Asklepios Paulinen Klinik, Wiesbaden, Germany., Kühn T; 32 Frauenklinik, Städtische Kliniken, Esslingen am Neckar, Germany., Krauss T; 33 Frauenklinik Lippe-Detmold, Detmold, Germany., Thomssen C; 34 Frauenklinik, Martin Luther University, Halle-Wittenberg, Germany., Hohn A; 35 Kreiskrankenhaus Rendsburg, Rendsburg, Germany., Tesch H; 36 Onkologie Bethanien Frankfurt, Frankfurt, Germany., Mundhenke C; 37 Frauenklinik, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany., Hein A; 1 Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-European Metropolitan area Nuremberg (CCC ER-EMN), Germany., Rauh C; 1 Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-European Metropolitan area Nuremberg (CCC ER-EMN), Germany., Bayer CM; 1 Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-European Metropolitan area Nuremberg (CCC ER-EMN), Germany., Jacob A; 38 Novartis Pharma GmbH, Nuremberg, Germany., Schmidt K; 38 Novartis Pharma GmbH, Nuremberg, Germany., Belleville E; 39 Clin-Sol GmbH, Würzburg, Germany., Hadji P; 40 Krankenhaus Nordwest, Klinik für Gynäkologie und Geburtshilfe, Frankfurt, Germany., Brucker SY; 3 Department für Frauengesundheit, Universitätsklinikum Tübingen, Eberhard-Karls-Universität, Tübingen, Germany., Wallwiener D; 3 Department für Frauengesundheit, Universitätsklinikum Tübingen, Eberhard-Karls-Universität, Tübingen, Germany., Kümmel S; 41 Brustzentrum, Kliniken Essen Mitte, Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany., Beckmann MW; 1 Universitäts-Brustzentrum Franken, Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-European Metropolitan area Nuremberg (CCC ER-EMN), Germany., Paepke D; 42 Frauenklinik rechts der Isar, Technische Universität München, Munich, Germany.

المصدر: Integrative cancer therapies [Integr Cancer Ther] 2017 Jun; Vol. 16 (2), pp. 165-175. Date of Electronic Publication: 2016 Sep 14.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Aromatase Inhibitors/*therapeutic use , Breast Neoplasms/*drug therapy , Nitriles/*therapeutic use , Postmenopause/*drug effects , Triazoles/*therapeutic use, Aged ; Female ; Germany ; Humans ; Integrative Medicine/methods ; Letrozole ; Middle Aged ; Prospective Studies

المؤلفون: Zhang T; Department of Oncology, Xiyuan Hospital of China Academy of Chinese Medicial Sciences, Beijing, 100091, China., He WT; Second Department of Oncology, Traditional Chinese Medicine, Hospital Affiliated to Xinjiang Medical University, Urumchi, 830001, China., Zi MJ; Ethics Committee, Xiyuan Hospital of China Academy of Chinese Medicial Sciences, Beijing, 100091, China., Song G; Department of Digestive Oncology, Beijing Cancer Hospital, Beijing, 100036, China., Yi DH; School of Statistics, Renmin University of China, Beijing, 100872, China., Yang YF; Department of Oncology, Xiyuan Hospital of China Academy of Chinese Medicial Sciences, Beijing, 100091, China. yyf93@vip.sina.com.

المصدر: Chinese journal of integrative medicine [Chin J Integr Med] 2018 Aug; Vol. 24 (8), pp. 573-578. Date of Electronic Publication: 2018 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Chinese Journal of Integrated Traditional and Western Medicine Press Country of Publication: China NLM ID: 101181180 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1993-0402 (Electronic) Linking ISSN: 16720415 NLM ISO Abbreviation: Chin J Integr Med Subsets: MEDLINE

مواضيع طبية MeSH: Integrative Medicine*, Antineoplastic Agents/*therapeutic use , Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*pathology , Drugs, Chinese Herbal/*therapeutic use, Aged ; Cohort Studies ; Colorectal Neoplasms/mortality ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Survival Rate

المؤلفون: Chen MH; The China-Australia International Research Centre for Chinese Medicine, School of Health Sciences, RMIT University, Bundoora, VIC, 3083, Australia., May BH; The China-Australia International Research Centre for Chinese Medicine, School of Health Sciences, RMIT University, Bundoora, VIC, 3083, Australia., Zhou IW; The China-Australia International Research Centre for Chinese Medicine, School of Health Sciences, RMIT University, Bundoora, VIC, 3083, Australia., Zhang AL; The China-Australia International Research Centre for Chinese Medicine, School of Health Sciences, RMIT University, Bundoora, VIC, 3083, Australia., Xue CC; The China-Australia International Research Centre for Chinese Medicine, School of Health Sciences, RMIT University, Bundoora, VIC, 3083, Australia.; Guangdong Provincial Academy of Chinese Medical Sciences and Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.

المصدر: Phytotherapy research : PTR [Phytother Res] 2016 May; Vol. 30 (5), pp. 741-53. Date of Electronic Publication: 2016 Feb 23.

نوع المنشور: Journal Article; Meta-Analysis; Review; Systematic Review

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1573 (Electronic) Linking ISSN: 0951418X NLM ISO Abbreviation: Phytother Res Subsets: MEDLINE

مواضيع طبية MeSH: Antiemetics/*therapeutic use , Antineoplastic Agents/*adverse effects , Colorectal Neoplasms/*drug therapy , Integrative Medicine/*methods , Nausea/*drug therapy , Organoplatinum Compounds/*adverse effects , Vomiting/*drug therapy, Animals ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/therapeutic use ; Oxaliplatin